ID: ALA4290590

Max Phase: Preclinical

Molecular Formula: C21H16Cl2N2O

Molecular Weight: 383.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc(C2=NN(c3cccc(Cl)c3)C(c3cccc(Cl)c3)C2)cc1

Standard InChI:  InChI=1S/C21H16Cl2N2O/c22-16-4-1-3-15(11-16)21-13-20(14-7-9-19(26)10-8-14)24-25(21)18-6-2-5-17(23)12-18/h1-12,21,26H,13H2

Standard InChI Key:  PYVVBCSYAJFJOP-UHFFFAOYSA-N

Associated Targets(Human)

Protein kinase C iota 2821 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Protein kinase C zeta 2414 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

RAW264.7 28094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 383.28Molecular Weight (Monoisotopic): 382.0640AlogP: 6.05#Rotatable Bonds: 3
Polar Surface Area: 35.83Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.07CX Basic pKa: 3.80CX LogP: 6.32CX LogD: 6.31
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.60Np Likeness Score: -1.08

References

1. Abdel-Halim M, Abadi AH, Engel M..  (2018)  Design and synthesis of novel 1,3,5-triphenyl pyrazolines as potential anti-inflammatory agents through allosteric inhibition of protein kinase Czeta (PKCζ).,  (6): [PMID:30108997] [10.1039/C8MD00100F]

Source